Harry Hollema

Groningen, GR 9700RB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

Journal: Journal of the National Cancer Institute

Published: September 25, 2024

Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.

Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.

Journal: Gynecologic oncology

Published: March 18, 2024

Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.

Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: May 05, 2023

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 22, 2023

Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients.

Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients.

Journal: Oncoimmunology

Published: June 14, 2021

Association of homozygous variants of STING1 with outcome in human cervical cancer.

Association of homozygous variants of STING1 with outcome in human cervical cancer.

Journal: Cancer science

Published: April 29, 2020

Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome.

Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome.

Journal: BMC women's health

Published: September 03, 2019

Two types of primary mucinous ovarian tumors can be distinguished based on their origin.

Two types of primary mucinous ovarian tumors can be distinguished based on their origin.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: August 29, 2019

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 13, 2019

Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls.

Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls.

Journal: Histopathology

Published: February 28, 2019

The Origin of Follicular Bile Acids in the Human Ovary.

The Origin of Follicular Bile Acids in the Human Ovary.

Journal: The American journal of pathology

Published: February 20, 2019

Margin status revisited in vulvar squamous cell carcinoma.

Margin status revisited in vulvar squamous cell carcinoma.

Journal: Gynecologic oncology

Published: February 11, 2019

Showing 1-12 of 75

Last Updated: 09/26/2026